Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease

World Journal of Surgery

Volumn 32, Issue 5, 2008, Pages 815-821

  Tominaga, Yoshihiro ^a   Tsuzuki, Toyonori ^a   Matsuoka, Susumu ^a   Uno, Nobuaki ^a   Sato, Tetsuhiko ^a   Shimabukuro, Syuichi ^a   Goto, Norihiko ^a   Nagasaka, Takaharu ^a   Uchida, Kazuharu ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFIBROMIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; DISTANT METASTATIC PARATHYROID TUMOR; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NECK; PARATHYROID CELL; PARATHYROID GLAND; PARATHYROID TUMOR; PARATHYROIDECTOMY; PROTEIN EXPRESSION; REOPERATION; SECONDARY HYPERPARATHYROIDISM; STAINING; THORAX METASTASIS;

ADULT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; RENAL DIALYSIS; RETROSPECTIVE STUDIES; THORACIC NEOPLASMS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS;

EID: 42449085287     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9458-8     Document Type: Article

References (21)

1. Thompson SD, Prichard AJN (2004) The management of parathyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg 12:93-97
2. Collins MT, Skarulis MC, Bilezikian JP et al (1998) Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent J Clin Endocrinol Metab 83:1083-1088
3. Khan MW, Worcester EM, Straus FH II et al (2004) Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. Am Coll Surg 199:312-319
4. Schntz A, Castleman B (1973) Parathyroid carcinoma. A study of 70 cases. Cancer 31:600-605
5. Grimelius L, Johansson H (1997) Pathology of parathyroid tumors. Semin Surg Oncol 13:142-145
6. Vargas MP, Vargas HI, Kleiner DE et al (1997) The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol 10:12-17
7. Chang YJ, Mithal V, Remin S et al (2006) Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma. Am Surgeon 72:419-426
8. Carpten JD, Robbins CM, Villablanca A et al (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-680
9. Shattuck TM, Valimaki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. New Engl J Med 349:1722-1729
10. Chen JD, Morrison C, Zhang C et al (2003) Hyperparathyroidism-jaw tumor syndrome. J Int Med 253:634-642
11. Howell VM, Haven CJ, Kahnoski K et al (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumors. J Med Genet 40:657-663
12. Certani F, Pardi E, Borsari S et al (2004) Genetic analysis of the HRPT2 gene in primary hyperparathyroidism: germ line and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583-5591
13. Krebs LJ, Shattuck TM, Arnold A et al (2005) HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab 90:5015-5017
14. Bradley KJ, Cavaco BM, Bowl MR et al (2006) Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumors. Clin Endocrinol 64:299-306
15. Tan MH, Morrison C, Wang P et al (2004) Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10:6629-6637
16. Gill JA, Clarkson A, Gimm O et al (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasia. Am J Surg Pathol 30:1140-1149
17. Akerstrom G, Rudberg C, Grimelius L et al (1988) Recurrent hyperparathyroidism due to preoperative seeding of neoplastic or hyperplasic parathyroid tissue. Acta Chir Scand 154:549-552
18. Matsuoka S, Tominaga Y, Sato T et al (2006) Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 31:299-305
19. Tominaga Y, Takagi H (1999) Mechanism of parathyroid tumorigenesis in uremia. Nephrol Dial Transplant 14 Suppl:63-65
20. Tominaga Y, Takagi H (1996) Molecular genetics of hyperparathyroid disease. Curr Opin Nephrol Hypertens 5:336-341
21. Tominaga Y, Tsuzuki T, Uchida K et al (1999) Expression of PRAD1/cyclin D1, retinoblastoma gene products, and KI 67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int 55:1375-1383